Prevalence of Oral Findings in Egyptian Patients Diagnosed With Familial Mediterranean Fever
Prevalence of Oral Findings in Egyptian Patients Diagnosed With Familial Mediterranean Fever: A Hospital-Based Cross-sectional Study
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Amr Mahmoud Almorsy, MSc candidate
- Phone Number: 01060964113 01014346192
- Email: amr.almorsy@dentistry.cu.edu.eg
Study Contact Backup
- Name: Noha Adel Ibrahim, Lecturer
- Phone Number: 01014346192 01001381954
- Email: noha.adel@dentistry@cu.edu.eg
Study Locations
-
-
-
Cairo, Egypt
- Collagen Diseases Clinic, Abu Elreesh Japanese Children's Hospital
-
Contact:
- Amr Mahmoud Alshafaey, MSc student
- Phone Number: 01060964113 01014346192
- Email: amr.almorsy@dentistry.cu.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Egyptian children aged 6 to 15 years
- Children with a confirmed diagnosis of Familial Mediterranean Fever (FMF)
- Children attending the Collagen Diseases Clinic at Abu Elreesh Japanese Children's Hospital.
Exclusion Criteria:
- Children with other systemic diseases not related to FMF
- Children who are unable to cooperate or refuse to participate
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
|---|
|
Egyptian children with FMF
Egyptian children aged 6 to 15 years, with a confirmed diagnosis of Familial Mediterranean Fever (FMF), attending the Collagen Diseases Clinic at Abu Elreesh Japanese Children's Hospital.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Oral Findings in Egyptian patients Diagnosed with Familial Mediterranean Fever
Time Frame: At enrollment ( single cross-sectional visit)
|
The data will be collected through clinical oral examination using a standardized dental chart, along with a review of their medical records.
The oral findings including high-arched palate, enamel defects, macroglossia, recurrent oral ulcers, and short philtrum will be reported as binary data (yes / no).
Binary data such as prevalence of oral manifestations will be reported as a proportion.
|
At enrollment ( single cross-sectional visit)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Fat'heya Mohamed Zahran, Professor, Cairo University
- Study Chair: noha adel ibrahim, lecturer, Cairo University
- Study Chair: Hend mohamed abu shaday, assistant professor, Cairo University
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- OMED 2-1-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.